Primary gastric non-Hodgkin's lymphoma: a clinicopathological study of 41 patients

Journal of Cancer Research and Clinical Oncology - Tập 121 - Trang 51-56 - 1995
R. Kath1, K. Donhuijsen2, J. Hayungs1, K. Albrecht3, S. Seeber1, K. Höffken1
1Department of Internal Medicine (Cancer Research), West German Tumor Center, University of Essen, medical School, Essen, Germany
2Department of Pathology, West German Tumor Center, University of Essen, Medical School, Essen, Germany
3Department of Surgery, University of Essen Medical School, Essen, Germany

Tóm tắt

Pathological findings in 41 patients (male/female ratio: 1.3/1) with primary localized gastric non-Hodgkin's lymphoma (NHL) were retrospectively studied and correlated with survival. The median observation period after diagnosis was 32 (0–189) months. Nineteen patients were low-grade NHL, all but one B-cell lymphomas of the mucosa-associated lymphoid tissue (MALT) type. Twenty-two patients had primary (n-7) or secondary (n=15) high-grade lymphomas; Musshoff stage IE was found in 29 and II E in 12 cases. The median age at diagnosis was 61 years (range, 26–88 years), and proliferation, measured by the number of mitosis and Ki-67 antigen positivity (MIB-1), was high or moderately high in 24 cases and low in 17 cases. Follicular lymphatic hyperplasia could be found in 25 of 34 evaluable cases, more often in low-grade than in high-grade NHL. Most of the patients were treated by resective surgery and additional ratio- or chemotherapy. Thirteen patients (31%) died (median survival: 10 months), 5 of them within 3 months after surgery owing to postoperative complications. Survival was superior, though not statistically significant, in low-grade lymphomas. Our retrospective anlysis of heterogeneously treated gastric lymphomas reveals that gastric lymphomas, especially of the low-grade MALT type, often remain a localized disease with a good long-term prognosis. Our study confirms previous reports indicating that lymphomas of the MALT type represent a specific clinicopathological entity.

Tài liệu tham khảo

Azab MB, Henry-Amar M, Rougier P, Bognel C, Theodore C, Carde P, Lasser P, Cosset M, Caillou B, Droz JP, Hayat M (1989) Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature. Cancer 64: 1208–1217 Azzopardi JG, Menzies T (1960) Primary malignant lymphoma of the alimentary tract. Br J Surg 47: 358–366 Bron D, Regnier R, Bleiberg H, Peetrons P, Pector JC, Stryckmanns P (1989) Controversies in the management of gastrointestinal non-Hodgkin's lymphomas. Eur J Surg Oncol 15: 547–522 Brooks JJ, Enterline HT (1983) Primary gastric lymphomas: a clinicopathologic study of 58 cases with long-term follow-up and literature review. Cancer 51: 701–711 Burgers MV, Heerde P van, Tio TL (1989) Primary non-Hodgkin's lymphoma of the stomach: changing aspects and therapeutic choices. Eur J Cancer Clin Oncol 25: 439–450 Cogliatti SB, Schmid U, Schumacher U, Eckert F, Hansmann ML, Hederich, J, Takahashi H, Lennert K (1991) Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 101: 1159–1170 Dawson IMP, Cornes JS, Morson BC (1961) Primary malignant lymphoid malignant tumors of the intestinal tract: report of 37 cases with a study of factors influencing prognosis. Br J Surg 49: 80–89 Domizio P, Owen RA, Shepherd NA, Talbot IC, Norton AJ (1993) Primary lymphoma of the small intestine. Am J Surg Pathol 17: 429–442 Donhuijsen K (1987) Mitoses in non-Hodgkin's lymphomas. Frequency and prognostic relevance. Pathol Res Pract 182: 352–357 Donhuijsen K, Hoppe B, Gross G, Sperling M (1994) Polymerase chain reaction and mRNA in situ hybridisation for gastric biopsy interpretation. 21st National Cancer Congress of the German Cancer Society (Hamburg, 7–11 March 1994), J Cancer Res Clin Oncol 120 [Suppl]: R49 Dorfman R, Burke JS, Berard CW (1982) A working formulation of non-Hodgkin's lymphomas: background, recommendations, histological criteria, and relationship to other classifications. In: Rosenberg SA, Kaplan HS (eds) Malignant lymphomas. Etiology, immunology, pathology, treatment. Bristol-Myers Cancer Symposia 3. Academic Press, New York, pp 351–368 Fischbach W, Böhm S, Wilms K (1993) Magenlymphome. Eine aktuelle Übersicht zu Inzidenz, histopathologischer Klassifikation, Stadieneinteilung, Prognose, Diagnostik und Therapie. Dtsch Ärzteblatt, Heft 24 [A 1]: 1797–1804 Fleming ID, Mitchell S, Dilawari RA (1982) The role of surgery in the management of gastric lymphoma. Cancer 49: 1135–1141 Haber DA, Mayer RJ (1988) Primary gastrointestinal lymphoma. Semin Oncol 15: 154–169 Horsman D, Gascoyne R, Klasa R, Coupland R (1992) t(11;18)(q21;21.1): A recurring translocation in lymphomas of mucosa-associated lymphoid tissue (MALT)? Genes Chromosomes Cancer 4: 183–187 Hünerbein M, Schlag PM (1994) Primary gastrointestinal lymphoma. Onkologie 17: 384–389 Isaacson PG, Wright DH (1983) Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 52: 1410–1416 Isaacson PG, Spencer GJ, Wright DH (1988) Classifying primary gut lymphomas. Lancet II: 1148–1149 Jähne J, Meyer HJ, Wilke H, Geerlings H, Pichlmayr R (1990) Die Bedeutung der chirurgischen Therapie bei primären und sekundären Non-Hodgkin-Lymphomen des Magens in multimodalen Behandlungskonzept. Tumordign Ther 11: 272–279 Maor MH, Velasquez WS, Fuller LM, Silvermintz KB (1990) Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma. J Clin Oncol 8: 266–271 Musshoff K (1977) Klinische Stadieneinteilung der Nicht-Hodgkin-Lymphome. Strahlentherapie 153: 218–221 Nizze H, Cogliatti SB, Schilling C von, Feller AC, Lennert K (1991) Monocytoid B-cell lymphoma: morphological variants and relationship to low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue. Histopathology 18: 403–414 Otter R, Bieger R, Kluin PM, Hermans J, Willemze R (1989) Primary gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer 60: 745–750 Price AB (1991) The sydney system: histological division. J Gastroenterol Hepatol 6: 209–222 Radaszkiewicz T, Dragosics B, Bauer P (1992) Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue. Factors relevant to prognosis. Gastroenterology 102: 1628–1638 Rao AR, Kagan AR, Potyk D, Nussbaum H, Chan P, Hintz BL, Wollin M, Ryoo MC (1984) Management of gastrointestinal lymphoma. Am J Clin Oncol 7: 213–219 Sack H, Budach V, Stuschke M et al. (1992) Non-Hodgkin lymphomas (NHL)—early stages interim results of a multicentre trial. J Cancer Res Clin Oncol 118 [Suppl]: R115 Salles G, Herbrecht R, Tilly H (1991) Aggressive primary gastrointestinal lymphoma: review of 91 patients treated with LNH-84 regimen. A study of the Groupe d'étude des lymphomes agressifs. Am J Med 90: 77–82 Severson RK, Davis S (1990) Increasing incidence of primary gastric lymphoma. Cancer 66: 1283–1287 Stolte M (1992)Helicobacter pylori gastritis and gastric MALT-lymphoma. Lancet I 339: 745–746 Wotherspoon AC, Oritz-Hidalgo C, Falzon MR, Isaacson PG (1991)Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338: 1175–1176 Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, Boni M, Isaacson PG (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication ofHelicobacter pylori. Lancet 342: 575–577